Rhumbline Advisers Merck & Co., Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
A detailed history of Rhumbline Advisers transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 4,463,320 shares of MRK stock, worth $371 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
4,463,320
Previous 4,517,345
1.2%
Holding current value
$371 Million
Previous $513 Million
13.45%
% of portfolio
0.41%
Previous 0.47%
Shares
30 transactions
Others Institutions Holding MRK
# of Institutions
3,946Shares Held
1.94BCall Options Held
16.1MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA251MShares$20.8 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$6.7 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.08 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $210B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...